Brian Gorman is of OPIANT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of OPNT, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 33,990 shares (Common Stock) at a price of $20.0 per share, resulting in proceeds of $679,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Brian Gorman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 02 2023
SELL
Sale (or disposition) back to the issuer
$679,800 $20.0 p/Share
33,990 Reduced 100.0%
0 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
2,000 Added 50.0%
2,000 Common Stock
Jan 27 2023
SELL
Open market or private sale
$8,995 $20.26 p/Share
444 Reduced 1.37%
31,990 Common Stock
Jan 05 2023
SELL
Open market or private sale
$26,522 $20.2 p/Share
1,313 Reduced 3.89%
32,434 Common Stock
Jul 14 2022
SELL
Open market or private sale
$7,712 $11.16 p/Share
691 Reduced 2.01%
33,747 Common Stock
Jun 27 2022
BUY
Grant, award, or other acquisition
-
2,000 Added 5.49%
34,438 Common Stock
Jun 02 2022
SELL
Open market or private sale
$15,521 $13.52 p/Share
1,148 Reduced 3.42%
32,438 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
12,000 Added 26.32%
33,586 Common Stock
Sep 14 2021
BUY
Open market or private purchase
$24,941 $19.01 p/Share
1,312 Added 5.73%
21,586 Common Stock
Jan 26 2021
BUY
Grant, award, or other acquisition
-
6,774 Added 25.04%
20,274 Common Stock
BG

Brian Gorman

Santa Monica, CA

Track Institutional and Insider Activities on OPNT

Follow OPIANT PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPNT shares.

Notify only if
Any

Insider Trading

Get notified when an Opiant Pharmaceuticals, Inc. insider buys or sells OPNT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to OPIANT PHARMACEUTICALS, INC.

Track Activities on OPNT